\babel@toc {english}{}\relax 
\contentsline {chapter}{\numberline {1}Introduction}{4}{chapter.1}%
\contentsline {section}{\numberline {1.1}Microbes}{4}{section.1.1}%
\contentsline {subsection}{\numberline {1.1.1}Prevalence of microbes}{4}{subsection.1.1.1}%
\contentsline {subsection}{\numberline {1.1.2}Difficulties in studying them}{4}{subsection.1.1.2}%
\contentsline {section}{\numberline {1.2}Genomics}{4}{section.1.2}%
\contentsline {subsection}{\numberline {1.2.1}Comparative genomics}{5}{subsection.1.2.1}%
\contentsline {subsection}{\numberline {1.2.2}Metagenomics}{5}{subsection.1.2.2}%
\contentsline {section}{\numberline {1.3}Leveraging computational power}{5}{section.1.3}%
\contentsline {subsection}{\numberline {1.3.1}Comparing low-throughput and high-throughput pipeline}{5}{subsection.1.3.1}%
\contentsline {chapter}{\numberline {2}\emph {Escherichia Coli} general informations}{6}{chapter.2}%
\contentsline {section}{\numberline {2.1}\emph {E. coli} genomics}{6}{section.2.1}%
\contentsline {subsection}{\numberline {2.1.1}\emph {E. coli} long-term evolution experiment}{6}{subsection.2.1.1}%
\contentsline {subsection}{\numberline {2.1.2}\emph {E. coli} strains}{7}{subsection.2.1.2}%
\contentsline {subsection}{\numberline {2.1.3}PanPhlAn - strain detection and characterization}{7}{subsection.2.1.3}%
\contentsline {subsection}{\numberline {2.1.4}Genomes of \emph {E. coli}}{7}{subsection.2.1.4}%
\contentsline {chapter}{\numberline {3}NGS principles (second gen. sequencing) - From Sanger to third gen sequencing}{10}{chapter.3}%
\contentsline {section}{\numberline {3.1}History of Sequencing}{10}{section.3.1}%
\contentsline {subsection}{\numberline {3.1.1}Progresses of sequencing}{10}{subsection.3.1.1}%
\contentsline {subsection}{\numberline {3.1.2}The Chain Terminators}{11}{subsection.3.1.2}%
\contentsline {subsection}{\numberline {3.1.3}Sanger method: the first one}{12}{subsection.3.1.3}%
\contentsline {subsubsection}{\numberline {3.1.3.1}Automatic sequencing}{13}{subsubsection.3.1.3.1}%
\contentsline {section}{\numberline {3.2}Development of Sequencing Machines}{14}{section.3.2}%
\contentsline {section}{\numberline {3.3}Next Generation Sequencing NGS}{16}{section.3.3}%
\contentsline {subsection}{\numberline {3.3.1}Fragments/Library preparation}{17}{subsection.3.3.1}%
\contentsline {subsection}{\numberline {3.3.2}Clonal amplification and ILLUMINA sequencing procedure}{17}{subsection.3.3.2}%
\contentsline {subsection}{\numberline {3.3.3}Pacific Bioscience (PacBio)}{20}{subsection.3.3.3}%
\contentsline {subsection}{\numberline {3.3.4}Nanopore sequencing}{20}{subsection.3.3.4}%
\contentsline {chapter}{\numberline {4}Sequencing data}{22}{chapter.4}%
\contentsline {section}{\numberline {4.1}Intro to sequencing raw data}{23}{section.4.1}%
\contentsline {subsection}{\numberline {4.1.1}Base caller}{23}{subsection.4.1.1}%
\contentsline {subsubsection}{\numberline {4.1.1.1}Errors solved by Ilumina's base caller}{24}{subsubsection.4.1.1.1}%
\contentsline {subsubsection}{\numberline {4.1.1.2}Density on the flow cell}{24}{subsubsection.4.1.1.2}%
\contentsline {subsubsection}{\numberline {4.1.1.3}An ecology of base callers}{25}{subsubsection.4.1.1.3}%
\contentsline {subsection}{\numberline {4.1.2}FASTQ format}{25}{subsection.4.1.2}%
\contentsline {subsubsection}{\numberline {4.1.2.1}Quality control: read length distribution}{25}{subsubsection.4.1.2.1}%
\contentsline {subsubsection}{\numberline {4.1.2.2}FastQC on PacBio vs ONT}{26}{subsubsection.4.1.2.2}%
\contentsline {subsection}{\numberline {4.1.3}Duplication artifacts}{27}{subsection.4.1.3}%
\contentsline {subsubsection}{\numberline {4.1.3.1}GC content analysis}{27}{subsubsection.4.1.3.1}%
\contentsline {subsubsection}{\numberline {4.1.3.2}K-mers frequency plot}{27}{subsubsection.4.1.3.2}%
\contentsline {subsubsection}{\numberline {4.1.3.3}Low-complexity artifacts}{27}{subsubsection.4.1.3.3}%
\contentsline {subsection}{\numberline {4.1.4}FASTQ quality control (QC)}{28}{subsection.4.1.4}%
\contentsline {chapter}{\numberline {5}Mapping}{29}{chapter.5}%
\contentsline {section}{\numberline {5.1}Mapping}{29}{section.5.1}%
\contentsline {subsubsection}{\numberline {5.1.0.1}Exercise on coverage}{30}{subsubsection.5.1.0.1}%
\contentsline {section}{\numberline {5.2}Mapping algorithm}{30}{section.5.2}%
\contentsline {subsection}{\numberline {5.2.1}Local vs Global alignment}{31}{subsection.5.2.1}%
\contentsline {subsection}{\numberline {5.2.2}Smith-Waterman algorithm (local alignment) - 1981}{31}{subsection.5.2.2}%
\contentsline {subsection}{\numberline {5.2.3}Needleman-Wunsch algorithm (global alignment)}{34}{subsection.5.2.3}%
\contentsline {subsection}{\numberline {5.2.4}BLAST (Basic Local Alignment Search Tool)}{35}{subsection.5.2.4}%
\contentsline {subsubsection}{\numberline {5.2.4.1}BLAST E-value}{36}{subsubsection.5.2.4.1}%
\contentsline {subsection}{\numberline {5.2.5}Speed seed alignment}{37}{subsection.5.2.5}%
\contentsline {subsection}{\numberline {5.2.6}Burrow-Wheeler alignment}{37}{subsection.5.2.6}%
\contentsline {subsection}{\numberline {5.2.7}LF (Last-First) property}{38}{subsection.5.2.7}%
\contentsline {subsection}{\numberline {5.2.8}Exact mapping using LF property}{39}{subsection.5.2.8}%
\contentsline {chapter}{\numberline {6}Assembly}{41}{chapter.6}%
\contentsline {section}{\numberline {6.1}Feasibility of sequence assembly}{43}{section.6.1}%
\contentsline {subsection}{\numberline {6.1.1}Last year exercise}{43}{subsection.6.1.1}%
\contentsline {subsection}{\numberline {6.1.2}Merging overlapping reads}{44}{subsection.6.1.2}%
\contentsline {subsection}{\numberline {6.1.3}Overlap graphs}{44}{subsection.6.1.3}%
\contentsline {section}{\numberline {6.2}How to solve an overlapping graph?}{45}{section.6.2}%
\contentsline {section}{\numberline {6.3}Graph simplification operations}{46}{section.6.3}%
\contentsline {subsection}{\numberline {6.3.1}De Brujin graph assembly}{47}{subsection.6.3.1}%
\contentsline {subsection}{\numberline {6.3.2}Scaffolding}{48}{subsection.6.3.2}%
\contentsline {subsection}{\numberline {6.3.3}Evaluating assemblies}{48}{subsection.6.3.3}%
\contentsline {chapter}{\numberline {7}16S-rRNA sequencing}{50}{chapter.7}%
\contentsline {section}{\numberline {7.1}Introduction to metagenomics}{50}{section.7.1}%
\contentsline {subsection}{\numberline {7.1.1}Definition of metagenomics}{50}{subsection.7.1.1}%
\contentsline {subsection}{\numberline {7.1.2}Why studying the metagenome}{50}{subsection.7.1.2}%
\contentsline {subsection}{\numberline {7.1.3}Differences with older microbiome studies}{50}{subsection.7.1.3}%
\contentsline {subsection}{\numberline {7.1.4}Example: skin microbiome}{51}{subsection.7.1.4}%
\contentsline {section}{\numberline {7.2}16S rRNA sequencing}{51}{section.7.2}%
\contentsline {subsection}{\numberline {7.2.1}Simplified 16S rRNA analysis workflow}{51}{subsection.7.2.1}%
\contentsline {subsection}{\numberline {7.2.2}16S rRNA gene}{51}{subsection.7.2.2}%
\contentsline {subsection}{\numberline {7.2.3}Primer and high-throughput machine choice}{52}{subsection.7.2.3}%
\contentsline {subsection}{\numberline {7.2.4}In depth 16S rRNA analysis workflow}{54}{subsection.7.2.4}%
\contentsline {subsection}{\numberline {7.2.5}OTU clustering}{55}{subsection.7.2.5}%
\contentsline {subsection}{\numberline {7.2.6}OTU taxonomic annotation}{57}{subsection.7.2.6}%
\contentsline {subsection}{\numberline {7.2.7}RDP classifier (Naive Bayes Model)}{58}{subsection.7.2.7}%
\contentsline {section}{\numberline {7.3}Diversity analysis}{59}{section.7.3}%
\contentsline {subsection}{\numberline {7.3.1}Alpha diversity analysis}{59}{subsection.7.3.1}%
\contentsline {subsection}{\numberline {7.3.2}Beta diversity analysis}{59}{subsection.7.3.2}%
\contentsline {section}{\numberline {7.4}Principal Coordinate Analysis (PCoA}{60}{section.7.4}%
\contentsline {section}{\numberline {7.5}Study: \textit {Enhanced microbial diversity in the saliva microbiome induced by short-term probiotic intake revealed by 16S rRNA sequencing on the IonTorrent PGM platform}}{60}{section.7.5}%
\contentsline {chapter}{\numberline {8}Shotgun Metagenomics}{63}{chapter.8}%
\contentsline {section}{\numberline {8.1}Workflow}{63}{section.8.1}%
\contentsline {section}{\numberline {8.2}Comparison with the 16s sequencing}{64}{section.8.2}%
\contentsline {section}{\numberline {8.3}Latest technology}{64}{section.8.3}%
\contentsline {section}{\numberline {8.4}Identification of microbes from Shotgun Metagenomics data: do we really need something fancy?}{65}{section.8.4}%
\contentsline {subsection}{\numberline {8.4.1}MetaPhlAn: unique marker genes for taxonomic profiling}{66}{subsection.8.4.1}%
\contentsline {subsubsection}{\numberline {8.4.1.1}The problem of the unknowns}{66}{subsubsection.8.4.1.1}%
\contentsline {subsection}{\numberline {8.4.2}Other approaches}{67}{subsection.8.4.2}%
\contentsline {subsection}{\numberline {8.4.3}The curatedMetagenomicData resource}{68}{subsection.8.4.3}%
\contentsline {subsection}{\numberline {8.4.4}The link between the gut microbiome and colorectal cancer}{68}{subsection.8.4.4}%
\contentsline {subsubsection}{\numberline {8.4.4.1}Hypothesis-driven analysis}{69}{subsubsection.8.4.4.1}%
\contentsline {section}{\numberline {8.5}PanPhlAn: strain-level profiling}{69}{section.8.5}%
\contentsline {subsection}{\numberline {8.5.1}Investigating population genomics thanks to PanPhlAn}{71}{subsection.8.5.1}%
\contentsline {subsubsection}{\numberline {8.5.1.1}\emph {E. coli} population genomics with PanPhlAn}{71}{subsubsection.8.5.1.1}%
\contentsline {subsubsection}{\numberline {8.5.1.2}PanPhlAn on \emph {Eubacterium rectale}}{73}{subsubsection.8.5.1.2}%
\contentsline {subsubsection}{\numberline {8.5.1.3}The infant gut microbiome in disease}{73}{subsubsection.8.5.1.3}%
\contentsline {subsection}{\numberline {8.5.2}StrainPhlAn: a complementary approach}{73}{subsection.8.5.2}%
\contentsline {subsection}{\numberline {8.5.3}StrainPhlAn applications}{74}{subsection.8.5.3}%
\contentsline {subsubsection}{\numberline {8.5.3.1}The stability of strains in the human gut}{74}{subsubsection.8.5.3.1}%
\contentsline {subsubsection}{\numberline {8.5.3.2}Identification of subspecies}{75}{subsubsection.8.5.3.2}%
\contentsline {subsection}{\numberline {8.5.4}Uncharacterized species}{75}{subsection.8.5.4}%
\contentsline {subsection}{\numberline {8.5.5}Applications of strain-level metagenomic profiling}{76}{subsection.8.5.5}%
\contentsline {subsubsection}{\numberline {8.5.5.1}\emph {E.rectale} refined population genomics}{76}{subsubsection.8.5.5.1}%
\contentsline {subsubsection}{\numberline {8.5.5.2}\emph {Prevotella copri} is strongly lifestyle-associated}{77}{subsubsection.8.5.5.2}%
\contentsline {subsubsection}{\numberline {8.5.5.3}Identification of \emph {Akkermansia} candidate subspecies}{78}{subsubsection.8.5.5.3}%
\contentsline {subsubsection}{\numberline {8.5.5.4}An example of eukaryotic microorganism: \emph {Blastocystis}}{79}{subsubsection.8.5.5.4}%
\contentsline {subsubsection}{\numberline {8.5.5.5}Bacteriophages profiling}{79}{subsubsection.8.5.5.5}%
\contentsline {subsection}{\numberline {8.5.6}HUMAnN2: Functional profiling}{80}{subsection.8.5.6}%
\contentsline {chapter}{\numberline {9}Staphylococcus aureus}{82}{chapter.9}%
\contentsline {section}{\numberline {9.1}Immune evasion strategies}{82}{section.9.1}%
\contentsline {section}{\numberline {9.2}Antibiotic resistance in \emph {S. aureus}}{83}{section.9.2}%
\contentsline {subsection}{\numberline {9.2.1}Methicillin-resistant \emph {S. aureus} (MRSA)}{83}{subsection.9.2.1}%
\contentsline {subsection}{\numberline {9.2.2}Methicillin resistance: where is it encoded?}{83}{subsection.9.2.2}%
\contentsline {subsection}{\numberline {9.2.3}Methicillin-resistant \emph {S. aureus} (MRSA)}{84}{subsection.9.2.3}%
\contentsline {subsubsection}{\numberline {9.2.3.1}\emph {S.aureus} worldwide}{84}{subsubsection.9.2.3.1}%
\contentsline {section}{\numberline {9.3}Whole genome epidemiology, characterization, and phylogenetic reconstruction of \emph {S. aureus} strains in a pediatric hospitals}{85}{section.9.3}%
\contentsline {subsection}{\numberline {9.3.1}Methods}{85}{subsection.9.3.1}%
\contentsline {subsection}{\numberline {9.3.2}Typing methods}{86}{subsection.9.3.2}%
\contentsline {subsection}{\numberline {9.3.3}MLST}{86}{subsection.9.3.3}%
\contentsline {subsection}{\numberline {9.3.4}Spa-typing}{86}{subsection.9.3.4}%
\contentsline {subsection}{\numberline {9.3.5}SCC\emph {mec}}{87}{subsection.9.3.5}%
\contentsline {subsection}{\numberline {9.3.6}PVL}{87}{subsection.9.3.6}%
\contentsline {subsection}{\numberline {9.3.7}The cohort}{88}{subsection.9.3.7}%
\contentsline {subsection}{\numberline {9.3.8}Typing highlights common clones and newly sequenced ones}{88}{subsection.9.3.8}%
\contentsline {subsection}{\numberline {9.3.9}Co-presence of local, global, animal-associated and hypervirulent clones}{88}{subsection.9.3.9}%
\contentsline {subsection}{\numberline {9.3.10}Genomic signature of chronic versus acute \emph {S. aureus} infections}{89}{subsection.9.3.10}%
\contentsline {subsection}{\numberline {9.3.11}Variability in SCC\emph {mec} cassettes}{89}{subsection.9.3.11}%
\contentsline {subsection}{\numberline {9.3.12}Diversity of virulence factors and antigens}{89}{subsection.9.3.12}%
\contentsline {subsection}{\numberline {9.3.13}Virulence factors with available vaccines targets}{90}{subsection.9.3.13}%
\contentsline {subsection}{\numberline {9.3.14}Phylogenetic of specific STs highlights the aggressive spread of a novel independently acquired ST$1$ clone}{90}{subsection.9.3.14}%
\contentsline {subsection}{\numberline {9.3.15}Conclusions}{91}{subsection.9.3.15}%
